Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators have developed a novel instrument for taking endometrial biopsies at no touch (vaginoscopic) hysterectomy which avoids the need to instrument the vagina with speculums and tenaculums, and also avoids the possible need for cervical dilatation. The investigators wish to study the ease of use and efficacy of the new device compared with traditional techniques of endometrial sampling at hysteroscopy.
| Condition | Intervention |
|---|---|
|
Abnormal Uterine Bleeding |
Procedure: Endometrial biopsy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy |
- Discomfort [ Time Frame: End of procedure ] [ Designated as safety issue: No ]
- Procedure time, biopsy adequacy [ Time Frame: End of procedure ] [ Designated as safety issue: No ]
| Enrollment: | 180 |
| Study Start Date: | January 2003 |
| Study Completion Date: | May 2007 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: H Pipelle
Endometrial sample obtained using the H Pipelle
|
Procedure: Endometrial biopsy
Endometrial biopsy taken on completion of office/outpatient diagnostic hysteroscopy
Other Names:
|
|
Active Comparator: Pipelle
Endometrial sample obtained with standard Pipelle
|
Procedure: Endometrial biopsy
Endometrial biopsy taken on completion of office/outpatient diagnostic hysteroscopy
Other Names:
|
Detailed Description:
We have developed a novel instrument for taking endometrial biopsies at no touch (vaginoscopic) hysterectomy which avoids the need to instrument the vagina with speculums and tenaculums, and also avoids the possible need for cervical dilatation. We wish to study the ease of use and efficacy of the new device compared with traditional techniques of endometrial sampling at hysteroscopy in terms of biopsy adequacy, the time taken to obtain a biopsy and patient experience.
Eligibility| Ages Eligible for Study: | 20 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Indication to carry out diagnostic hysteroscopy
- Agrees and is suitable for outpatient/office hysteroscopy
Exclusion Criteria:
- Failed outpatient/office hysteroscopy
Contacts and Locations| United Kingdom | |
| Royal Free Hospital | |
| London, United Kingdom, NW3 2QG | |
| Principal Investigator: | Adam Magos, BSc MD FRCOG | Royal Free Hospital, London |
More Information
Publications:
| Responsible Party: | Adam Magos BSc MB BS MD FRCOG, Consultant Gynaecologist, Royal Free Hospital |
| ClinicalTrials.gov Identifier: | NCT00755651 History of Changes |
| Other Study ID Numbers: | REC 6056 |
| Study First Received: | September 18, 2008 |
| Last Updated: | September 18, 2008 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by Royal Free Hampstead NHS Trust:
|
Menorrhagia Uterine fibroids Endometrial polyps Endometrial cancer |
Additional relevant MeSH terms:
|
Hemorrhage Uterine Hemorrhage Adenoma Pathologic Processes Uterine Diseases |
Genital Diseases, Female Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on June 18, 2013